Welcome and Introduction (ID 4909)
Historical Adjuvant Treatment of Melanoma: Have we made a difference? (ID 4910)
Debate: High risk early stage melanoma patients should not be treated with systemic adjuvant therapy (ID 4912)
Debate: High risk early stage melanoma patients should be treated with systemic adjuvant therapy (ID 4911)
Adjuvant treatment of high-risk melanoma: What is the future? (ID 4913)
Panel Discussion - Question and Answers (ID 4914)
Closing Remarks (ID 4915)